

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.15218544 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.15218544 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.85087865 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.85087865 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.48969009 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.11268362 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.11268362 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.11268362 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.05868087 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.94003402 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.83646743 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.76545570 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.71573371 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 5.49642291 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 5.48569160 |
| 16 | regulation of protein activation cascade (GO:2000257) | 5.48118924 |
| 17 | cysteine metabolic process (GO:0006534) | 5.43437518 |
| 18 | complement activation, alternative pathway (GO:0006957) | 5.42625460 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.38063982 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34067449 |
| 21 | regulation of fibrinolysis (GO:0051917) | 5.33663922 |
| 22 | urea metabolic process (GO:0019627) | 5.30892487 |
| 23 | urea cycle (GO:0000050) | 5.30892487 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24555681 |
| 25 | protein carboxylation (GO:0018214) | 5.24555681 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.19856637 |
| 27 | regulation of complement activation (GO:0030449) | 5.12592803 |
| 28 | reverse cholesterol transport (GO:0043691) | 4.89771104 |
| 29 | bile acid metabolic process (GO:0008206) | 4.89694712 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.86670675 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.84764566 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.74746809 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.73241974 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.71830752 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.68714606 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.66746073 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.66746073 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.66746073 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.50236253 |
| 40 | phospholipid efflux (GO:0033700) | 4.49403494 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.49373496 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.49373496 |
| 43 | omega-hydroxylase P450 pathway (GO:0097267) | 4.49124487 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.47210835 |
| 45 | lysine catabolic process (GO:0006554) | 4.44192214 |
| 46 | lysine metabolic process (GO:0006553) | 4.44192214 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.37304398 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.33865663 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.33865663 |
| 50 | benzene-containing compound metabolic process (GO:0042537) | 4.32922581 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.31509530 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.31214992 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.29671401 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 4.27545611 |
| 55 | cellular biogenic amine catabolic process (GO:0042402) | 4.24975904 |
| 56 | amine catabolic process (GO:0009310) | 4.24975904 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.19394560 |
| 58 | cellular glucuronidation (GO:0052695) | 4.17074842 |
| 59 | cholesterol efflux (GO:0033344) | 4.14838276 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.14600049 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.13780392 |
| 62 | response to nitrosative stress (GO:0051409) | 4.12939431 |
| 63 | ethanol oxidation (GO:0006069) | 4.07136139 |
| 64 | fibrinolysis (GO:0042730) | 4.06674425 |
| 65 | glutamate metabolic process (GO:0006536) | 4.06085106 |
| 66 | glycolipid catabolic process (GO:0019377) | 4.05862356 |
| 67 | low-density lipoprotein particle clearance (GO:0034383) | 4.02630525 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.01354744 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 4.00694732 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.00486968 |
| 71 | polyketide metabolic process (GO:0030638) | 4.00455660 |
| 72 | doxorubicin metabolic process (GO:0044598) | 4.00455660 |
| 73 | daunorubicin metabolic process (GO:0044597) | 4.00455660 |
| 74 | glycine metabolic process (GO:0006544) | 3.99545473 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.97382342 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.92140579 |
| 77 | regulation of cholesterol homeostasis (GO:2000188) | 3.87320348 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.85638604 |
| 79 | complement activation, classical pathway (GO:0006958) | 3.85075210 |
| 80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78503788 |
| 81 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78503788 |
| 82 | glucuronate metabolic process (GO:0019585) | 3.75290662 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.75290662 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74982246 |
| 85 | arginine metabolic process (GO:0006525) | 3.74973076 |
| 86 | complement activation (GO:0006956) | 3.74968923 |
| 87 | cofactor catabolic process (GO:0051187) | 3.73130808 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 3.72402057 |
| 89 | blood coagulation, intrinsic pathway (GO:0007597) | 3.72222642 |
| 90 | cytolysis (GO:0019835) | 3.71049918 |
| 91 | protein activation cascade (GO:0072376) | 3.71018572 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.70634977 |
| 93 | oligosaccharide catabolic process (GO:0009313) | 3.70252544 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.67287601 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.65253275 |
| 96 | opsonization (GO:0008228) | 3.64308901 |
| 97 | drug catabolic process (GO:0042737) | 3.64297868 |
| 98 | acute-phase response (GO:0006953) | 3.63715629 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.63646890 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62469094 |
| 101 | sterol homeostasis (GO:0055092) | 3.61408422 |
| 102 | plasma lipoprotein particle organization (GO:0071827) | 3.60863639 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.59462140 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.59324103 |
| 105 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.57768175 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.57342084 |
| 107 | urate metabolic process (GO:0046415) | 3.57188037 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.55674319 |
| 109 | organic acid catabolic process (GO:0016054) | 3.55674319 |
| 110 | negative regulation of protein activation cascade (GO:2000258) | 3.54656854 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.54292001 |
| 112 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.48145337 |
| 113 | positive regulation of extracellular matrix organization (GO:1903055) | 3.42628100 |
| 114 | glycoside metabolic process (GO:0016137) | 3.39952802 |
| 115 | ceramide catabolic process (GO:0046514) | 3.37607794 |
| 116 | exogenous drug catabolic process (GO:0042738) | 3.35445872 |
| 117 | negative regulation of blood coagulation (GO:0030195) | 3.29451151 |
| 118 | negative regulation of hemostasis (GO:1900047) | 3.29451151 |
| 119 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.23342276 |
| 120 | adhesion of symbiont to host (GO:0044406) | 3.19105242 |
| 121 | membrane lipid catabolic process (GO:0046466) | 3.18120836 |
| 122 | negative regulation of coagulation (GO:0050819) | 3.17888595 |
| 123 | cellular response to arsenic-containing substance (GO:0071243) | 3.10915348 |
| 124 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.08855089 |
| 125 | regulation of mononuclear cell migration (GO:0071675) | 3.07176474 |
| 126 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.05474773 |
| 127 | regulation of cholesterol storage (GO:0010885) | 3.05173098 |
| 128 | response to thyroid hormone (GO:0097066) | 3.05011041 |
| 129 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.02666868 |
| 130 | primary alcohol catabolic process (GO:0034310) | 3.01240612 |
| 131 | sphingolipid catabolic process (GO:0030149) | 2.97859764 |
| 132 | regulation of superoxide anion generation (GO:0032928) | 2.97466774 |
| 133 | regulation of vitamin metabolic process (GO:0030656) | 2.94176664 |
| 134 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.93532748 |
| 135 | fructose metabolic process (GO:0006000) | 2.93245956 |
| 136 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90192392 |
| 137 | ethanol metabolic process (GO:0006067) | 2.88874692 |
| 138 | drug metabolic process (GO:0017144) | 2.87866585 |
| 139 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.87566379 |
| 140 | negative regulation of wound healing (GO:0061045) | 2.87103065 |
| 141 | positive regulation of blood coagulation (GO:0030194) | 2.85065101 |
| 142 | positive regulation of hemostasis (GO:1900048) | 2.85065101 |
| 143 | cyclooxygenase pathway (GO:0019371) | 2.85058078 |
| 144 | positive regulation of coagulation (GO:0050820) | 2.84463057 |
| 145 | flavonoid metabolic process (GO:0009812) | 2.82144948 |
| 146 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.78835092 |
| 147 | protein localization to endosome (GO:0036010) | 2.78406289 |
| 148 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.77236802 |
| 149 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.74704607 |
| 150 | regulation of early endosome to late endosome transport (GO:2000641) | 2.74468638 |
| 151 | intestinal cholesterol absorption (GO:0030299) | 2.71716918 |
| 152 | glucose 6-phosphate metabolic process (GO:0051156) | 2.68828132 |
| 153 | NIK/NF-kappaB signaling (GO:0038061) | 2.67438894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.92794792 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.93021765 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.63565784 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23214350 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.97541650 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.78814961 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69269522 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.84648631 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.82433945 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.66439981 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.00951730 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3510041 |
| 13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98540990 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96601562 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95184148 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.92619017 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91936518 |
| 18 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89325247 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86795372 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79692908 |
| 21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63677615 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59752948 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58175521 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51207528 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48054068 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46562123 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46421642 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43537093 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38860446 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37473679 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35948713 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32186447 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31932016 |
| 34 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29287799 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27664658 |
| 36 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25237320 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25141550 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21535044 |
| 39 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20902006 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.20746131 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20456182 |
| 42 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20448475 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20149872 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19676206 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18576535 |
| 46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18181773 |
| 47 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18024597 |
| 48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17135244 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14950448 |
| 50 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.13628083 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13394743 |
| 52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13287239 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12673769 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12388978 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11246823 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08959935 |
| 57 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07312188 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06657136 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05858284 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05446619 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04029739 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04027609 |
| 63 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03507385 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.03445754 |
| 65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02278956 |
| 66 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01089596 |
| 67 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00894739 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00799594 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99889622 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98792157 |
| 71 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97959401 |
| 72 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97390267 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96959303 |
| 74 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96889437 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96701179 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95831684 |
| 77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95829548 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95574911 |
| 79 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95376786 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94617974 |
| 81 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94159466 |
| 82 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94159466 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93380809 |
| 84 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93080573 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93053208 |
| 86 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.92612724 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 0.92407089 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89793777 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85706349 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77554496 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77013520 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76569665 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74851335 |
| 94 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73329489 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71140247 |
| 96 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.71091001 |
| 97 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70810656 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70793400 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70378704 |
| 100 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68339453 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.67367136 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66859639 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66399128 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66388338 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66168334 |
| 106 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65093481 |
| 107 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65093481 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65079214 |
| 109 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65043026 |
| 110 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63183940 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62849080 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62491703 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62216827 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62211904 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62190966 |
| 116 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61434374 |
| 117 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60233071 |
| 118 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58256801 |
| 119 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.57890354 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57009663 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.56612252 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55823615 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55401472 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.54890249 |
| 125 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52884375 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52815183 |
| 127 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.52489439 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.52409680 |
| 129 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52084604 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.52048613 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51941218 |
| 132 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51494734 |
| 133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51058199 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50715473 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50214902 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.49814041 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49258582 |
| 138 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.49060148 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48625241 |
| 140 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48525891 |
| 141 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.48510314 |
| 142 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48184645 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.45286439 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45108987 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.45081793 |
| 146 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44659076 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44486709 |
| 148 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.44089613 |
| 149 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.42397298 |
| 150 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.42355211 |
| 151 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.42266025 |
| 152 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.41713217 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.41557027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.93787248 |
| 2 | MP0005360_urolithiasis | 7.11286742 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13357681 |
| 4 | MP0005365_abnormal_bile_salt | 5.92965344 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87034204 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.09380902 |
| 7 | MP0003252_abnormal_bile_duct | 3.91314982 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.52022373 |
| 9 | MP0009840_abnormal_foam_cell | 3.33212438 |
| 10 | MP0005083_abnormal_biliary_tract | 3.14420289 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.71665454 |
| 12 | MP0003195_calcinosis | 2.67399531 |
| 13 | MP0005332_abnormal_amino_acid | 2.64610121 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.44282637 |
| 15 | MP0003303_peritoneal_inflammation | 2.40366282 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.36965841 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.32265262 |
| 18 | MP0000609_abnormal_liver_physiology | 2.16169575 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.15964866 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.04936066 |
| 21 | MP0004510_myositis | 2.01757457 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.90443800 |
| 23 | MP0000343_altered_response_to | 1.78456217 |
| 24 | MP0003868_abnormal_feces_composition | 1.76320352 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.72906165 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.60351170 |
| 27 | MP0001764_abnormal_homeostasis | 1.59862395 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.55968281 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52797349 |
| 30 | MP0003186_abnormal_redox_activity | 1.41820583 |
| 31 | MP0000371_diluted_coat_color | 1.40938191 |
| 32 | MP0003011_delayed_dark_adaptation | 1.38077054 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.34391367 |
| 34 | MP0009697_abnormal_copulation | 1.34374729 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.33750181 |
| 36 | MP0008260_abnormal_autophagy | 1.29081938 |
| 37 | MP0002254_reproductive_system_inflammat | 1.26994217 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.26456759 |
| 39 | MP0000858_altered_metastatic_potential | 1.24436150 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.23400954 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.21351823 |
| 42 | MP0004233_abnormal_muscle_weight | 1.20856493 |
| 43 | MP0009764_decreased_sensitivity_to | 1.20756375 |
| 44 | MP0000598_abnormal_liver_morphology | 1.20558566 |
| 45 | MP0005451_abnormal_body_composition | 1.17867767 |
| 46 | MP0005647_abnormal_sex_gland | 1.15764417 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.15617901 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.13331014 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.11146089 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.11064486 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.07797995 |
| 52 | MP0005025_abnormal_response_to | 1.07675036 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.07324501 |
| 54 | MP0006054_spinal_hemorrhage | 1.06888045 |
| 55 | MP0002332_abnormal_exercise_endurance | 1.05280588 |
| 56 | MP0009763_increased_sensitivity_to | 1.04870741 |
| 57 | MP0008469_abnormal_protein_level | 1.04749858 |
| 58 | MP0000604_amyloidosis | 0.99509368 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 0.98578531 |
| 60 | MP0005670_abnormal_white_adipose | 0.95794650 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 0.93983000 |
| 62 | MP0001545_abnormal_hematopoietic_system | 0.93983000 |
| 63 | MP0005000_abnormal_immune_tolerance | 0.92849706 |
| 64 | MP0009642_abnormal_blood_homeostasis | 0.90141900 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 0.89789683 |
| 66 | MP0010155_abnormal_intestine_physiology | 0.89324497 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.87688138 |
| 68 | MP0005408_hypopigmentation | 0.84035781 |
| 69 | MP0003448_altered_tumor_morphology | 0.83986637 |
| 70 | MP0002928_abnormal_bile_duct | 0.82799783 |
| 71 | MP0003436_decreased_susceptibility_to | 0.81879519 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.81306626 |
| 73 | MP0003724_increased_susceptibility_to | 0.80824564 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.80682494 |
| 75 | MP0008004_abnormal_stomach_pH | 0.80097514 |
| 76 | MP0000920_abnormal_myelination | 0.79678296 |
| 77 | MP0005165_increased_susceptibility_to | 0.79319709 |
| 78 | MP0005248_abnormal_Harderian_gland | 0.78725258 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.78600684 |
| 80 | MP0005387_immune_system_phenotype | 0.78172792 |
| 81 | MP0001790_abnormal_immune_system | 0.78172792 |
| 82 | MP0002090_abnormal_vision | 0.77856943 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.77116581 |
| 84 | MP0001849_ear_inflammation | 0.76457910 |
| 85 | MP0002971_abnormal_brown_adipose | 0.74069851 |
| 86 | MP0009278_abnormal_bone_marrow | 0.73463708 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.72754180 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.72316076 |
| 89 | MP0005334_abnormal_fat_pad | 0.71383227 |
| 90 | MP0009053_abnormal_anal_canal | 0.70283054 |
| 91 | MP0009333_abnormal_splenocyte_physiolog | 0.69554389 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.68940127 |
| 93 | MP0003879_abnormal_hair_cell | 0.67223396 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.66546826 |
| 95 | MP0001915_intracranial_hemorrhage | 0.65720192 |
| 96 | MP0002452_abnormal_antigen_presenting | 0.65153006 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.64892419 |
| 98 | MP0005410_abnormal_fertilization | 0.64316734 |
| 99 | MP0002723_abnormal_immune_serum | 0.64200453 |
| 100 | MP0001756_abnormal_urination | 0.64116329 |
| 101 | MP0003091_abnormal_cell_migration | 0.62896405 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.62419588 |
| 103 | MP0005310_abnormal_salivary_gland | 0.61484644 |
| 104 | MP0003690_abnormal_glial_cell | 0.60539890 |
| 105 | MP0003075_altered_response_to | 0.58161869 |
| 106 | MP0005535_abnormal_body_temperature | 0.58066987 |
| 107 | MP0005166_decreased_susceptibility_to | 0.56987901 |
| 108 | MP0005266_abnormal_metabolism | 0.56966156 |
| 109 | MP0004130_abnormal_muscle_cell | 0.55586364 |
| 110 | MP0002132_abnormal_respiratory_system | 0.54304833 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.54031309 |
| 112 | MP0001661_extended_life_span | 0.48365629 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.48324251 |
| 114 | MP0006082_CNS_inflammation | 0.48090346 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.47985981 |
| 116 | MP0005448_abnormal_energy_balance | 0.47641895 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.46162157 |
| 118 | MP0008873_increased_physiological_sensi | 0.43949079 |
| 119 | MP0009785_altered_susceptibility_to | 0.43590253 |
| 120 | MP0005395_other_phenotype | 0.43543080 |
| 121 | MP0001853_heart_inflammation | 0.43285362 |
| 122 | MP0003329_amyloid_beta_deposits | 0.42902359 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.42774064 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.42685330 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.42186748 |
| 126 | MP0004883_abnormal_blood_vessel | 0.41479442 |
| 127 | MP0000249_abnormal_blood_vessel | 0.41421459 |
| 128 | MP0005023_abnormal_wound_healing | 0.41210754 |
| 129 | MP0003953_abnormal_hormone_level | 0.41083842 |
| 130 | MP0005164_abnormal_response_to | 0.38773054 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.38175184 |
| 132 | MP0008874_decreased_physiological_sensi | 0.37956095 |
| 133 | MP0002796_impaired_skin_barrier | 0.37724263 |
| 134 | MP0009115_abnormal_fat_cell | 0.37483376 |
| 135 | MP0000579_abnormal_nail_morphology | 0.37421722 |
| 136 | MP0004947_skin_inflammation | 0.37205402 |
| 137 | MP0001881_abnormal_mammary_gland | 0.37099505 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.36229511 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.35277886 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.34679536 |
| 141 | MP0003718_maternal_effect | 0.33911630 |
| 142 | MP0002419_abnormal_innate_immunity | 0.33793054 |
| 143 | MP0004381_abnormal_hair_follicle | 0.33767646 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.32916904 |
| 145 | MP0001243_abnormal_dermal_layer | 0.32742305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.13847362 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.10771896 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.95674001 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.35703147 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.28908403 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.13238727 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.13238727 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 6.13238727 |
| 9 | Xanthomatosis (HP:0000991) | 6.07362243 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 5.96436854 |
| 11 | Complement deficiency (HP:0004431) | 5.77754284 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.07584159 |
| 13 | Joint hemorrhage (HP:0005261) | 4.85473516 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.69775367 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.56310836 |
| 16 | Fat malabsorption (HP:0002630) | 4.27863831 |
| 17 | Abnormality of complement system (HP:0005339) | 4.25290004 |
| 18 | Hyperammonemia (HP:0001987) | 4.23052965 |
| 19 | Dysostosis multiplex (HP:0000943) | 4.21512360 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15633293 |
| 21 | Epidermoid cyst (HP:0200040) | 4.14957406 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 4.14883275 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14700609 |
| 24 | Hyperglycinemia (HP:0002154) | 4.12195715 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.03286447 |
| 26 | Ketosis (HP:0001946) | 4.02718437 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.94914931 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.93522531 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81472413 |
| 30 | Hyperglycinuria (HP:0003108) | 3.80206325 |
| 31 | Loss of speech (HP:0002371) | 3.74888435 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.72489302 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.71214824 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71214824 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.68813398 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.65886015 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.64150428 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.64150428 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.64150428 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59935280 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.56099399 |
| 42 | Mucopolysacchariduria (HP:0008155) | 3.54543720 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.54543720 |
| 44 | Spontaneous abortion (HP:0005268) | 3.39188459 |
| 45 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33233257 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.31419920 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 3.31288323 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.31153210 |
| 49 | Steatorrhea (HP:0002570) | 3.30019820 |
| 50 | Axonal loss (HP:0003447) | 3.29884659 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27193163 |
| 52 | Hyperbilirubinemia (HP:0002904) | 3.24555041 |
| 53 | Myocardial infarction (HP:0001658) | 3.20309722 |
| 54 | Disinhibition (HP:0000734) | 3.08581379 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07270931 |
| 56 | Vascular calcification (HP:0004934) | 3.05458332 |
| 57 | Prolonged neonatal jaundice (HP:0006579) | 3.05357701 |
| 58 | Increased serum ferritin (HP:0003281) | 3.01415305 |
| 59 | Nuclear cataract (HP:0100018) | 3.00214038 |
| 60 | Gout (HP:0001997) | 2.96996131 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.96119843 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94704555 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.94289768 |
| 64 | Ketoacidosis (HP:0001993) | 2.86842372 |
| 65 | Purpura (HP:0000979) | 2.82380594 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.80272561 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.76400479 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.75101058 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.72548577 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.71813648 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.68547458 |
| 72 | Glomerulonephritis (HP:0000099) | 2.63487184 |
| 73 | Abnormality of macrophages (HP:0004311) | 2.62660982 |
| 74 | Mitral stenosis (HP:0001718) | 2.61811362 |
| 75 | Amyloidosis (HP:0011034) | 2.61602152 |
| 76 | Metabolic acidosis (HP:0001942) | 2.60007589 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.55728651 |
| 78 | Cerebral inclusion bodies (HP:0100314) | 2.54497410 |
| 79 | Mutism (HP:0002300) | 2.51840169 |
| 80 | Skin nodule (HP:0200036) | 2.51551847 |
| 81 | Gingival bleeding (HP:0000225) | 2.48954679 |
| 82 | Achilles tendon contracture (HP:0001771) | 2.48808412 |
| 83 | Esophageal varix (HP:0002040) | 2.44049932 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.43705600 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.41208228 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.40480145 |
| 87 | Lethargy (HP:0001254) | 2.40237155 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.40106255 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40106255 |
| 90 | Malnutrition (HP:0004395) | 2.40002735 |
| 91 | Cholecystitis (HP:0001082) | 2.38458488 |
| 92 | Abnormal gallbladder physiology (HP:0012438) | 2.38458488 |
| 93 | J-shaped sella turcica (HP:0002680) | 2.38450107 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.38089892 |
| 95 | Neonatal onset (HP:0003623) | 2.37372186 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 2.36825925 |
| 97 | Late onset (HP:0003584) | 2.33862146 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32937440 |
| 99 | Cholelithiasis (HP:0001081) | 2.32712826 |
| 100 | Acanthocytosis (HP:0001927) | 2.32593829 |
| 101 | Thrombophlebitis (HP:0004418) | 2.30686945 |
| 102 | Sensorimotor neuropathy (HP:0007141) | 2.28704940 |
| 103 | Pancreatitis (HP:0001733) | 2.27253774 |
| 104 | Menorrhagia (HP:0000132) | 2.25520542 |
| 105 | Spastic diplegia (HP:0001264) | 2.24547323 |
| 106 | Pathologic fracture (HP:0002756) | 2.23521982 |
| 107 | Hemorrhage of the eye (HP:0011885) | 2.21289941 |
| 108 | Irritability (HP:0000737) | 2.17148720 |
| 109 | Progressive neurologic deterioration (HP:0002344) | 2.14999180 |
| 110 | Enlarged kidneys (HP:0000105) | 2.14520888 |
| 111 | Tetraparesis (HP:0002273) | 2.10901595 |
| 112 | Apathy (HP:0000741) | 2.10740561 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.10661995 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09436203 |
| 115 | Hydroxyprolinuria (HP:0003080) | 2.08223918 |
| 116 | Abnormality of proline metabolism (HP:0010907) | 2.08223918 |
| 117 | Diminished motivation (HP:0000745) | 2.07722791 |
| 118 | Distal lower limb muscle weakness (HP:0009053) | 2.07720610 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 2.07332562 |
| 120 | Retinal atrophy (HP:0001105) | 2.06769280 |
| 121 | Brushfield spots (HP:0001088) | 2.04205260 |
| 122 | Paraparesis (HP:0002385) | 2.03942846 |
| 123 | Bone pain (HP:0002653) | 2.03653124 |
| 124 | Vomiting (HP:0002013) | 2.01428550 |
| 125 | Cerebral edema (HP:0002181) | 2.00589339 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 2.00406725 |
| 127 | Rickets (HP:0002748) | 2.00134051 |
| 128 | Opisthotonus (HP:0002179) | 1.96119117 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96115502 |
| 130 | Nephritis (HP:0000123) | 1.95904798 |
| 131 | Neuronal loss in central nervous system (HP:0002529) | 1.95311835 |
| 132 | Hyperuricemia (HP:0002149) | 1.94992185 |
| 133 | Increased purine levels (HP:0004368) | 1.94992185 |
| 134 | Cardiomegaly (HP:0001640) | 1.92014998 |
| 135 | Nausea (HP:0002018) | 1.89804167 |
| 136 | Autoimmune thrombocytopenia (HP:0001973) | 1.89545629 |
| 137 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88279301 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86250550 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.84381693 |
| 140 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84140361 |
| 141 | Hypophosphatemia (HP:0002148) | 1.83921598 |
| 142 | Hypophosphatemic rickets (HP:0004912) | 1.83527652 |
| 143 | Thoracic kyphosis (HP:0002942) | 1.83517662 |
| 144 | Abnormal cartilage morphology (HP:0002763) | 1.81589501 |
| 145 | Poikilocytosis (HP:0004447) | 1.79500755 |
| 146 | Proximal tubulopathy (HP:0000114) | 1.79412725 |
| 147 | Renal cortical cysts (HP:0000803) | 1.77106684 |
| 148 | Alkalosis (HP:0001948) | 1.76351674 |
| 149 | Metaphyseal irregularity (HP:0003025) | 1.76121793 |
| 150 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73418061 |
| 151 | Dementia (HP:0000726) | 1.71551872 |
| 152 | Conjunctival telangiectasia (HP:0000524) | 1.69356281 |
| 153 | Hypertriglyceridemia (HP:0002155) | 1.68553078 |
| 154 | Peripheral demyelination (HP:0011096) | 1.68078864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.06016530 |
| 2 | ERN1 | 5.10490325 |
| 3 | NME2 | 4.40329793 |
| 4 | FGFR4 | 4.39277976 |
| 5 | SIK1 | 3.87601873 |
| 6 | TAOK3 | 3.31563534 |
| 7 | DDR2 | 3.02834013 |
| 8 | ERBB4 | 2.86279341 |
| 9 | TESK1 | 2.48174572 |
| 10 | INSRR | 2.39456372 |
| 11 | MST1R | 2.10608199 |
| 12 | PIM2 | 2.07772908 |
| 13 | TYK2 | 2.00816073 |
| 14 | MAP3K3 | 1.84144248 |
| 15 | GRK7 | 1.84120481 |
| 16 | PRPF4B | 1.82865092 |
| 17 | PTK6 | 1.81976798 |
| 18 | TRIB3 | 1.81548253 |
| 19 | MAPK11 | 1.72483463 |
| 20 | EPHB1 | 1.67839159 |
| 21 | MATK | 1.63204466 |
| 22 | MAPK15 | 1.62490800 |
| 23 | ACVR1B | 1.62211339 |
| 24 | TBK1 | 1.59137797 |
| 25 | SIK3 | 1.58631520 |
| 26 | MAP2K3 | 1.57746742 |
| 27 | PIK3CG | 1.53856109 |
| 28 | MAP2K4 | 1.51911693 |
| 29 | IRAK3 | 1.50565738 |
| 30 | MAP3K14 | 1.49703442 |
| 31 | TGFBR2 | 1.44826278 |
| 32 | PKN2 | 1.43316293 |
| 33 | PAK4 | 1.42561414 |
| 34 | FLT3 | 1.40554347 |
| 35 | MAP3K7 | 1.38809075 |
| 36 | FGR | 1.34644553 |
| 37 | NEK9 | 1.32847451 |
| 38 | FRK | 1.28430589 |
| 39 | LATS1 | 1.26253339 |
| 40 | DAPK2 | 1.19195068 |
| 41 | JAK2 | 1.16881342 |
| 42 | CDC42BPA | 1.16678301 |
| 43 | RIPK1 | 1.14191393 |
| 44 | PDK2 | 1.14021647 |
| 45 | MAP3K11 | 1.10365906 |
| 46 | LIMK1 | 1.07940407 |
| 47 | KDR | 1.06704227 |
| 48 | JAK1 | 1.06301006 |
| 49 | MAP2K2 | 1.02374980 |
| 50 | ABL2 | 1.02333620 |
| 51 | PDGFRA | 1.01863816 |
| 52 | IKBKE | 0.98828318 |
| 53 | PRKAA2 | 0.96785081 |
| 54 | ARAF | 0.95190296 |
| 55 | LATS2 | 0.94602818 |
| 56 | TTN | 0.94500307 |
| 57 | EPHA2 | 0.94287383 |
| 58 | BLK | 0.93152452 |
| 59 | GRK6 | 0.92640127 |
| 60 | MAPKAPK3 | 0.92326397 |
| 61 | MAP3K10 | 0.92217280 |
| 62 | MOS | 0.91728497 |
| 63 | DYRK1B | 0.90442340 |
| 64 | PTK2 | 0.88420589 |
| 65 | MAPK4 | 0.88412100 |
| 66 | EPHA3 | 0.87822228 |
| 67 | ERBB2 | 0.87348742 |
| 68 | MET | 0.84999228 |
| 69 | CSK | 0.84551016 |
| 70 | TIE1 | 0.84127888 |
| 71 | MARK3 | 0.82046908 |
| 72 | IRAK2 | 0.80601423 |
| 73 | IRAK4 | 0.78565671 |
| 74 | MAP2K6 | 0.74894183 |
| 75 | STK38L | 0.74778454 |
| 76 | CDK6 | 0.74015069 |
| 77 | FGFR2 | 0.70803012 |
| 78 | BMPR2 | 0.70591388 |
| 79 | PRKCZ | 0.69715824 |
| 80 | GSK3A | 0.65355402 |
| 81 | PINK1 | 0.65165448 |
| 82 | SMG1 | 0.64323911 |
| 83 | MAP3K12 | 0.61089449 |
| 84 | MAP3K2 | 0.60655602 |
| 85 | PDPK1 | 0.59640718 |
| 86 | IKBKB | 0.58922551 |
| 87 | CSF1R | 0.57077785 |
| 88 | PBK | 0.56686423 |
| 89 | MAP3K1 | 0.55402108 |
| 90 | MUSK | 0.55137313 |
| 91 | CHUK | 0.54967308 |
| 92 | SGK3 | 0.54690446 |
| 93 | PRKACG | 0.53405204 |
| 94 | MAPK12 | 0.53143833 |
| 95 | ZAP70 | 0.52561011 |
| 96 | TAOK2 | 0.52502860 |
| 97 | CAMK1D | 0.52039288 |
| 98 | FGFR3 | 0.50752876 |
| 99 | MAP3K8 | 0.50657589 |
| 100 | MAPK7 | 0.50026910 |
| 101 | MAP4K1 | 0.49084765 |
| 102 | PRKAA1 | 0.48726533 |
| 103 | EIF2AK1 | 0.48611085 |
| 104 | CAMK2G | 0.47774180 |
| 105 | MAP2K1 | 0.45786725 |
| 106 | GRK1 | 0.44021584 |
| 107 | PAK3 | 0.43680063 |
| 108 | PDK4 | 0.43637017 |
| 109 | PDK3 | 0.43637017 |
| 110 | KIT | 0.42913292 |
| 111 | MAP3K5 | 0.41467451 |
| 112 | PRKG2 | 0.40214903 |
| 113 | BMX | 0.40061590 |
| 114 | ICK | 0.39741523 |
| 115 | DYRK3 | 0.39231227 |
| 116 | BTK | 0.39210357 |
| 117 | IGF1R | 0.38978466 |
| 118 | TYRO3 | 0.38576790 |
| 119 | SCYL2 | 0.37615239 |
| 120 | IRAK1 | 0.37122901 |
| 121 | EGFR | 0.36959131 |
| 122 | STK38 | 0.36419505 |
| 123 | PDK1 | 0.36102739 |
| 124 | KSR2 | 0.35707368 |
| 125 | RIPK4 | 0.34904135 |
| 126 | EPHB2 | 0.34352557 |
| 127 | PRKCQ | 0.34066341 |
| 128 | CAMK4 | 0.33866779 |
| 129 | SGK2 | 0.33520326 |
| 130 | BRAF | 0.33412050 |
| 131 | TAOK1 | 0.33242048 |
| 132 | TESK2 | 0.32919799 |
| 133 | RPS6KL1 | 0.31453912 |
| 134 | RPS6KC1 | 0.31453912 |
| 135 | MYLK | 0.31421608 |
| 136 | PRKD2 | 0.31263938 |
| 137 | CAMKK2 | 0.30968956 |
| 138 | MTOR | 0.30744175 |
| 139 | MAPKAPK2 | 0.30557689 |
| 140 | AKT3 | 0.30398920 |
| 141 | ABL1 | 0.29444055 |
| 142 | JAK3 | 0.28370075 |
| 143 | RPS6KA2 | 0.28198368 |
| 144 | LMTK2 | 0.28157648 |
| 145 | FER | 0.27873869 |
| 146 | NLK | 0.27003101 |
| 147 | STK3 | 0.26989295 |
| 148 | STK10 | 0.26696610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54016443 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36962513 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.36902316 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.23058282 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00955869 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94591856 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84687009 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68230650 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55375497 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49622898 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49108335 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44415313 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37618757 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.32712918 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.28662854 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.13311989 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10870979 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.07088614 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00168743 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96773400 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96510192 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95376308 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89699200 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82570521 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81808403 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73481370 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70464673 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70033085 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69426626 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65244240 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54265474 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49616734 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48528565 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.47956361 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44514828 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40596215 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.40505107 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37171585 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35761717 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34602385 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32649696 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32424754 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28023231 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25184401 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.23265094 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21861753 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17416264 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14101503 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13951866 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12227028 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09275921 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08998655 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06881333 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06815975 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.04566722 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00382295 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99846028 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99116468 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98537355 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98446709 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98411435 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93716984 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93381107 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91902161 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90715471 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.89992199 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87161049 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86720006 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86682992 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.86297606 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79674040 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77169025 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.74262249 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.70991130 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70861613 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.70140035 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66289017 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64743839 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62117344 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62089612 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61173282 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.59353549 |
| 83 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55640587 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52893378 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51292030 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50595158 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47225048 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.43653826 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43106972 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41567143 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41409997 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.41072944 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37524501 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.35014190 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34515366 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31055103 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29663827 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.29521981 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.27143826 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.25249047 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.23069312 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22402165 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20064182 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10585273 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02292537 |
| 106 | Lysosome_Homo sapiens_hsa04142 | -0.1881059 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1821692 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1727266 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1548798 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1430902 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | -0.1414228 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1385596 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | -0.1280954 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1221403 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1042864 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0955806 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0923272 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0914203 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | -0.0876900 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0844446 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0839648 |
| 122 | Pertussis_Homo sapiens_hsa05133 | -0.0726874 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0438761 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0385007 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | -0.0347387 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0201790 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0046411 |

